| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | |
Gross Profit
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development | 3,524 | 5,566 | 11,040 |
|
Selling General and Administrative | 4,455 | 6,491 | 14,590 |
|
Non Recurring |
-
|
-
| 425 |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(7,979)
|
(12,057)
|
(26,055)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 8 | 35 | 1,339 |
|
Earnings Before Interest And Taxes | (7,971) | (12,022) | (24,716) |
|
Interest Expense |
-
|
-
| 6 |
|
Income Before Tax | (7,971) | (12,022) | (24,722) |
|
Income Tax Expense |
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (7,971) | (12,022) | (24,722) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(7,971)
|
(12,022)
|
(24,722)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(7,971)
|
(12,022)
|
(24,722)
|
|